Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience
Salah Mohamed El Sayed1,2 1Department of Clinical Biochemistry and Molecular Medicine, Taibah College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia; 2Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt Abstract: 3-Bromopyruvate (3B...
Guardado en:
Autor principal: | El Sayed SM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd6316f945344f6aa8793bac816c16ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide
por: Zhang L, et al.
Publicado: (2018) -
Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery
por: Tsolou A, et al.
Publicado: (2020) -
Multifunctional Mitochondria-Targeting Nanosystems for Enhanced Anticancer Efficacy
por: Tingting Hu, et al.
Publicado: (2021) -
Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation
por: Hong SS, et al.
Publicado: (2016) -
Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
por: Sun J, et al.
Publicado: (2017)